Form 4: Tenet Healthcare Director Receives Equity Grant

Director Vineeta Agarwala was granted 1,188 restricted stock units as part of Tenet Healthcare's incentive plan.

Summary

• Director Vineeta Agarwala received a grant of 1,188 restricted stock units (RSUs) on May 27, 2026.
• Each RSU represents the economic equivalent of one share of Tenet Healthcare common stock.
• The units are scheduled to vest on May 27, 2027, the first anniversary of the grant date.
• The reporting person has the option to receive up to 37% of the vested units in cash rather than shares.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral administrative filing regarding routine director compensation.

Positives

• Alignment of director interests with long-term shareholder value through equity-based compensation.

Negatives

• None identified; this is a standard compensatory equity grant.

Risks

• Value of the equity grant is subject to market fluctuations in Tenet Healthcare common stock price.

Future Outlook

The restricted stock units will vest on May 27, 2027, at which point the director will receive shares or a combination of shares and cash.

Industry Context

StockSavvy.ai notes that equity grants to board members are standard corporate governance practices designed to ensure directors maintain a vested interest in the company's long-term performance, consistent with practices at other large-cap healthcare providers.

Comparison to Industry Standards

• The grant structure is consistent with standard equity compensation packages for non-employee directors in the healthcare sector.
• The one-year vesting period is a common industry practice for director equity awards.

Stakeholder Impact

• Minimal impact on shareholders as the grant represents a standard component of director compensation.

Next Steps

• Vesting of the restricted stock units on May 27, 2027.

Key Dates

Keywords

Tenet Healthcare, THC, Form 4, Insider Trading, Equity Compensation, Director Compensation